跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
focal adhesion kinase
首页
药物
focal adhesion kinase
focal adhesion kinase
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOUNDS AND COMPOSITION AS PROTEIN KINASE INHIBITORS
EP 3012249 A1
申请人: NOVARTIS AG
优先权: 2006
CN
EP
US
14 件公开
Inhibitors of focal adhesion kinase
EP 2727909 A1
申请人: SCRIPPS RESEARCH INST
优先权: 2007
CN
EP
US
6 件公开
Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation
US 12178940 B2
申请人: UNIV LELAND STANFORD JUNIOR
优先权: 2018
CN
EP
US
WO
5 件公开
Adamantane derivatives as inhibitors of focal adhesion kinase
US 12590070 B2
申请人: SAMJIN PHARM CO LTD
优先权: 2019
CN
EP
US
WO
5 件公开
PEPTIDE INHIBITORS OF FOCAL ADHESION KINASE ACTIVITY AND USES THEREOF
EP 4021475 A4
申请人: UNIV ARIZONA
优先权: 2019
EP
US
WO
5 件公开
PYRIMIDINE OR PYRIDINE DERIVATIVE AND MEDICINAL USE THEREOF
EP 4450493 A4
申请人: SIGNET THERAPEUTICS INC
优先权: 2021
CN
EP
US
WO
4 件公开
2,4,DI (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
US 7067522 B2
申请人: ASTRAZENECA AB
优先权: 2000
US
4 件公开
METHODS FOR TREATING ADULT RESPIRATORY DISTRESS SYNDROME
US 2012027742 A1
申请人: BHATTACHARYA JAHAR
优先权: 2007
US
WO
3 件公开
Synthesis and use of kinase inhibitors
US 9505719 B2
申请人: VERASTEM INC
优先权: 2011
CN
US
3 件公开
Method of administration and treatment
US 9192604 B2
申请人: AUGER KURT R
优先权: 2012
CN
US
3 件公开
第 1 / 7 页
上一页
下一页
药物
反馈